|
74 Companies |
|
57 Products |
|
57 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
680 News |
|
| «12...234567891011121314 |
- Trial termination: A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 5, 2012
P2, N=11, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Completed --> Terminated; Terminated due to slow recruitment.
- | Trial completion: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) (clinicaltrials.gov) - Jan 4, 2012
P3, N=375, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Completed --> Terminated; Terminated due to slow recruitment. Active, not recruiting --> Completed
- Trial completion: Reducing Health Problems Associated With Injection Drug Use (clinicaltrials.gov) - Jan 2, 2012
P=N/A, N=87, Completed, Sponsor: University of Northern Colorado
Active, not recruiting --> Completed Recruiting --> Completed
- gevokizumab (S 78989) / Novartis
Trial withdrawal: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (clinicaltrials.gov) - Dec 29, 2011
P1/2, N=0, Withdrawn, Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting --> Completed Completed --> Withdrawn
- gevokizumab (S 78989) / Novartis
Enrollment change: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (clinicaltrials.gov) - Dec 29, 2011
P1/2, N=0, Withdrawn, Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed --> Withdrawn N=21 --> 0
- |||||| ceftaroline fosamil / Generic mfg.
Enrollment open: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections (clinicaltrials.gov) - Dec 28, 2011
P2/3, N=270, Recruiting, Sponsor: Cerexa, Inc.
N=21 --> 0 Not yet recruiting --> Recruiting
- |||||||||| aztreonam / Generic mfg., vancomycin / Generic mfg., ceftaroline fosamil / Generic mfg.
New P3 trial: Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections (clinicaltrials.gov) - Dec 22, 2011
P3, N=765, Recruiting, Sponsor: AstraZeneca
- clindamycin phosphate / Generic mfg.
Clinical: Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess (clinicaltrials.gov) - Dec 19, 2011
P=N/A, N=250, Recruiting, Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
- gentamicin sulfate / Generic mfg.
New P2 trial: WR 279,396 Open Label Treatment Protocol in Tunisia (clinicaltrials.gov) - Dec 15, 2011
P2, N=120, Suspended, Sponsor: U.S. Army Medical Research and Materiel Command
- | Veregen (sinecatechins) / Sinphar Pharma, Medigene
New P1 trial: Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers (clinicaltrials.gov) - Dec 1, 2011
P1, N=30, Completed, Sponsor: MediGene
- | valacyclovir / Generic mfg., acyclovir / Generic mfg.
Trial completion: Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV (clinicaltrials.gov) - Dec 1, 2011
P4, N=28, Completed, Sponsor: University of Washington
Not yet recruiting --> Recruiting Recruiting --> Completed
- | New P2 trial: Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail (clinicaltrials.gov) - Nov 30, 2011
P2, N=25, Completed, Sponsor: Nitric BioTherapeutics, Inc
- New P1 trial: Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Nov 30, 2011
P1, N=36, Completed, Sponsor: Infectious Disease Research Institute
- gentamicin sulfate / Generic mfg.
Trial completion: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) (clinicaltrials.gov) - Nov 29, 2011
P2, N=30, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis (clinicaltrials.gov) - Nov 16, 2011
P1, N=5, Completed, Sponsor: Southern California University of Health Sciences
Active, not recruiting --> Completed Recruiting --> Completed
- | New P4 trial: A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts (clinicaltrials.gov) - Nov 6, 2011
P4, N=242, Not yet recruiting, Sponsor: University of British Columbia
- ||||||| Havrix (hepatitis A vaccine, inactivated) / GSK
Trial completion: HerpeVac Trial for Young Women (clinicaltrials.gov) - Nov 1, 2011
P3, N=8323, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed
- || pentoxifylline / Generic mfg.
New P2/3 trial, IO biomarker, Immunomodulating: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis (clinicaltrials.gov) - Nov 1, 2011
P2/3, N=100, Recruiting, Sponsor: Centro Internacional de Entrenamiento e Investigaciones M
- ||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Enrollment change: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - Oct 27, 2011
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals
Active, not recruiting --> Completed N=240 --> 300
- gentamicin sulfate / Generic mfg.
Trial completion: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama (clinicaltrials.gov) - Oct 25, 2011
P2, N=30, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
N=240 --> 300 Active, not recruiting --> Completed
- | New P4 trial: Pharmacokinetics of Miltefosine in Children and Adults (clinicaltrials.gov) - Oct 24, 2011
P4, N=60, Recruiting, Sponsor: Centro Internacional de Entrenamiento e Investigaciones Médicas
- | tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
Enrollment open: Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection (clinicaltrials.gov) - Oct 23, 2011
P3, N=2900, Recruiting, Sponsor: CONRAD
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Oct 13, 2011
P=N/A, N=106380, Enrolling by invitation, Sponsor: Duke University
Not yet recruiting --> Recruiting Not yet recruiting --> Enrolling by invitation
- Trial completion: Genetics: Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (clinicaltrials.gov) - Oct 5, 2011
P=N/A, N=900, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Enrolling by invitation Recruiting --> Completed
- | tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
New P4 trial: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding (clinicaltrials.gov) - Oct 5, 2011
P4, N=55, Recruiting, Sponsor: University of Washington
- Enrollment change: MASH: Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study (clinicaltrials.gov) - Oct 2, 2011
P4, N=12, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed N=35 --> 12
- amphotericin b liposome / Generic mfg.
New P1/2 trial, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Sep 18, 2011
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- |||||||||| New P3 trial: Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis (clinicaltrials.gov) - Sep 11, 2011
P3, N=290, Completed, Sponsor: Novartis
- |||||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
New P2b trial: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - Sep 8, 2011
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals
- |||||||||| Zeven (dalbavancin) / RaQualia, AbbVie
New P3 trial: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (clinicaltrials.gov) - Sep 7, 2011
P3, N=739, Completed, Sponsor: Durata Therapeutics, Inc.
- IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Sep 5, 2011
P=N/A, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Trial completion: Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis (clinicaltrials.gov) - Sep 1, 2011
P2, N=46, Completed, Sponsor: University of Cologne
N=35 --> 12 Recruiting --> Completed
- Enrollment open: Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis (clinicaltrials.gov) - Aug 31, 2011
P=N/A, N=20, Recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting --> Completed Not yet recruiting --> Recruiting
- ciclopirox topical / Generic mfg.
New P4 trial: Topical Penlac Nail Lacquer for Onychomycosis in Children (clinicaltrials.gov) - Aug 16, 2011
P4, N=40, Completed, Sponsor: Rady Children's Hospital, San Diego
- ||||| Cubicin (daptomycin) / Merck (MSD)
New P4 trial, HEOR: DAPHEOR1006: Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA (clinicaltrials.gov) - Aug 16, 2011
P4, N=250, Completed, Sponsor: Cubist Pharmaceuticals
- Enrollment change: B-19 Parvovirus Vaccine Study (clinicaltrials.gov) - Aug 11, 2011
P1/2, N=43, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting N=89 --> 43
- ||| Trial completion: An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults (clinicaltrials.gov) - Aug 11, 2011
P1, N=449, Completed, Sponsor: Pfizer
N=89 --> 43 Active, not recruiting --> Completed